dc.contributor | Universidade Estadual Paulista (UNESP) | |
dc.contributor | Innovatecs Biotechnological Research and Development | |
dc.contributor | University of New South Wales | |
dc.date.accessioned | 2022-05-01T09:47:24Z | |
dc.date.accessioned | 2022-12-20T03:43:52Z | |
dc.date.available | 2022-05-01T09:47:24Z | |
dc.date.available | 2022-12-20T03:43:52Z | |
dc.date.created | 2022-05-01T09:47:24Z | |
dc.date.issued | 2022-02-01 | |
dc.identifier | Materials Letters, v. 308. | |
dc.identifier | 1873-4979 | |
dc.identifier | 0167-577X | |
dc.identifier | http://hdl.handle.net/11449/233719 | |
dc.identifier | 10.1016/j.matlet.2021.131109 | |
dc.identifier | 2-s2.0-85117583640 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5413818 | |
dc.description.abstract | We evaluated the feasibility of Nanoskin®, a bacterial cellulose (BC) nanofiber membrane, as a potential scaffold for cell transference therapy. Nanoskin® does not induce lymphocyte proliferation, but it does not kill lymphocytes. Human mesenchymal stem cells (MSCs) and lymphocytes produced significantly elevated amounts of interleukin (IL)-10 (p = 0.0005; p = 0.02) when in contact with Nanoskin®. In conclusion, the Nanoskin® can be a promising biomaterial for use as a cell carrier-scaffold in cell transference therapies. | |
dc.language | eng | |
dc.relation | Materials Letters | |
dc.source | Scopus | |
dc.subject | Bacterial cellulose | |
dc.subject | Cell transference | |
dc.subject | Nanoskin® | |
dc.subject | Regenerative medicine | |
dc.subject | Scaffold | |
dc.title | Physical, functional and biochemical features of Nanoskin® bacterial cellulose scaffold as a potential carrier for cell transference | |
dc.type | Artículos de revistas | |